Matches in Nanopublications for { ?s ?p "[Our results argue that EMMPRIN drives breast cancer-induced osteolytic lesions and that activation of the RANKL pathway increases EMMPRIN in osteotropic tumor cells, in turn enhancing tumor-induced bone resorption.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP415318.RAdw5A7Q0HrwN0QvHAG2TEkFhH1idkwx4fulQhEfzKQNA130_assertion description "[Our results argue that EMMPRIN drives breast cancer-induced osteolytic lesions and that activation of the RANKL pathway increases EMMPRIN in osteotropic tumor cells, in turn enhancing tumor-induced bone resorption.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP415318.RAdw5A7Q0HrwN0QvHAG2TEkFhH1idkwx4fulQhEfzKQNA130_provenance.
- NP256173.RAgk3LIgB4Qt0zdG2iQpKNwOqB7B4CvNwTDATIAOWE3x8130_assertion description "[Our results argue that EMMPRIN drives breast cancer-induced osteolytic lesions and that activation of the RANKL pathway increases EMMPRIN in osteotropic tumor cells, in turn enhancing tumor-induced bone resorption.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256173.RAgk3LIgB4Qt0zdG2iQpKNwOqB7B4CvNwTDATIAOWE3x8130_provenance.
- NP199424.RAIroQjAW0FrOcLK8qTdNVIJ89wiQn0s327Mheum_cZqs130_assertion description "[Our results argue that EMMPRIN drives breast cancer-induced osteolytic lesions and that activation of the RANKL pathway increases EMMPRIN in osteotropic tumor cells, in turn enhancing tumor-induced bone resorption.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP199424.RAIroQjAW0FrOcLK8qTdNVIJ89wiQn0s327Mheum_cZqs130_provenance.
- NP789680.RAI6t9JormVovjaiBt2JoliKtmTtWLo6riw4HpiuzfVAU130_assertion description "[Our results argue that EMMPRIN drives breast cancer-induced osteolytic lesions and that activation of the RANKL pathway increases EMMPRIN in osteotropic tumor cells, in turn enhancing tumor-induced bone resorption.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789680.RAI6t9JormVovjaiBt2JoliKtmTtWLo6riw4HpiuzfVAU130_provenance.
- assertion description "[Our results argue that EMMPRIN drives breast cancer-induced osteolytic lesions and that activation of the RANKL pathway increases EMMPRIN in osteotropic tumor cells, in turn enhancing tumor-induced bone resorption.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our results argue that EMMPRIN drives breast cancer-induced osteolytic lesions and that activation of the RANKL pathway increases EMMPRIN in osteotropic tumor cells, in turn enhancing tumor-induced bone resorption.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.